Quvozelt

View On IC.GC.CA

APPROVED

on 18 Mar 2025

Last Applicant/ Owned by

CELLTRION, INC.

23, Academy-ro, Yeonsu-guIncheon 22014

Serial Number

2250387 filed on 6^th Mar 2023

Correspondent Address

MBM INTELLECTUAL PROPERTY AGENCY

275 SLATER STREET14TH FLOOROTTAWA

ONTARIO

K1P5H9

Quvozelt

Trademark usage description

pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the treatment of tumours.

Classification Information

2250387

Trademark

Action Taken	Status
Submitted for opposition 48 on 2^th Aug 2024	Agent Changed
Submitted for opposition 22 on 5^th Jul 2024	Search Recorded
Submitted for opposition 20 on 5^th Jul 2024	Examiner's First Report
Submitted for opposition 223 on 5^th Jul 2024	Total Provisional Refusal
Submitted for opposition 256 on 6^th Feb 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 6^th Apr 2023	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 5^th Apr 2023	Created
Submitted for opposition 31 on 5^th Apr 2023	Formalized
Submitted for opposition 30 on 6^th Mar 2023	Filed
Submitted for opposition 228 on 6^th Mar 2023	International Registration